Health Care: Drugs

United Therapeutics Corp (UTHR: NASDAQ)

$132.355 n/a | n/a%
10/24/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 132.36
52 Week High 136.93
52 Week Low 81.83
Avg. Daily Vol. (Mil) 0.94
Beta (3 year) 1.39
Share Related Items
Mkt Cap (Mil) 6,256.34
Shares Out (Mil) 47.27
Float (Mil) 36.05
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.20
Current Ratio 1.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.31
Valuation Ratios
Price Earnings 26.10
Price/Sales 5.20
Price/Book 5.33
Price/Cash Flow 18.90
Per Share Data
Earnings 5.08
Sales 25.46
Book Value 24.83
Cash Flow 7.00
Business Summary
United Therapeutics Corp is a biotechnology company, which is focused on the development and commercialization of products to address the medical needs of patients with chronic and life-threatening conditions.
General Information
1040 Spring Street
Silver Spring, MD 20910
Industry : Drugs
Sector: Health Care
Employees: 706
CEO: Martine A. Rothblatt,PhD
Short Interest
Current Month (Mil) 4.60
Previous Month (Mil) 5.35
Short Interest Ratio (Days) 4.30
Management Effectiveness
Return on Equity 24.00
Return on Assets 14.40
Return on Investments 24.00
Gross Margin 92.50
EBIT Margin 39.40
Profit Margin 23.40

Portfolios with UTHR

Latest UTHR Headlines from TheStreet

More Financial News for UTHR

Press Releases for UTHR

See All Press Releases

Partner Headlines for UTHR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter